Original Research
Published on 01 Jul 2021
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2021.704767
- 5,416 views
- 10 citations

